Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Serhat SAYIN"'
Autor:
Serhat Sayin, Fatoş Dilan Atilla
Publikováno v:
Ankara Medical Journal, Vol 19, Iss 3, Pp 694-697 (2019)
Huzursuz bacak sendromu (HBS) bacaklarda hareket etme dürtüsü ile kendini gösteren, şikayetlerin istirahatte arttığı, bacaklarda rahatsızlık veren duyumlar ile karakterize uyku ilişkili bir hastalık olarak tanımlanmış nörolojik duyusa
Externí odkaz:
https://doaj.org/article/94e3efe6fd90408b9bb71e8246aa8193
Publikováno v:
Cukurova Medical Journal, Vol 44, Iss 2, Pp 479-485 (2019)
Amaç: Çalışmamızda dünyada ve ülkemizde önemli bir halk sağlığı sorunu olan, ve prevalansı giderek artan tip 2 diyabetli hastaların anksiyete ve depresyon risklerini belirlemeyi ve bu risklerle ilişkili durumları tespit etmeyi amaçla
Externí odkaz:
https://doaj.org/article/a8bec10c193146ab94f605e6ef27f8a5
Publikováno v:
Cukurova Medical Journal, Vol 44, Iss 1, Pp 287-289 (2019)
Externí odkaz:
https://doaj.org/article/cdfae5884c554cee96c319b6dd5c9119
Publikováno v:
Medicine Science, Vol 7, Iss 1, Pp 235-237 (2018)
Vildagliptin is a new generation theurapeutic agent of diabetes mellitus which belongs to dipeptidyl peptidase-IV inhibitor class acting via the incretin hormone system. It has moderate glycemic efficacy, a low propensity of causing hypoglycaemia and
Externí odkaz:
https://doaj.org/article/a384dc58bf8f49c38228c9550d36882a
Publikováno v:
Cukurova Medical Journal, Vol 44, Iss 1, Pp 285-286 (2019)
Externí odkaz:
https://doaj.org/article/8d620ae3354a445abbd303bb4e9d52f0
Autor:
Serhat Sayin, Metin Bagci
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction Carbamazepine is an antiepileptic drug used in the treatment of epilepsy, trigeminal neuralgia, and bipolar disorder. Hematological effects that may develop with this anticonvulsant; agranulocytosis, thrombocytopenia, leukopenia, aplasti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c539957ed7f1b5d3cda267fc49c2a4dd
https://pubmed.ncbi.nlm.nih.gov/35656781
https://pubmed.ncbi.nlm.nih.gov/35656781
Publikováno v:
Turkiye Klinikleri Journal of Internal Medicine. 4:43-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aedeaa1e605a9203904e3f2860443a66
https://doi.org/10.5336/intermed.2018-64255
https://doi.org/10.5336/intermed.2018-64255
Autor:
Bülent Eser, Turgay Ulas, Serdal Korkmaz, Ali Dogan, Asli Kum, Ahmet Sarici, Fevzi Altuntaş, Omer Ekinci, Serhat Sayin, Abdulkadir Basturk, Irfan Kuku, Ilhami Berber, Mehmet Ali Erkurt
Publikováno v:
Transfusion and Apheresis Science. 60:103246
Immune Thrombocytopenia (ITP) is an autoimmune disease characterized by thrombocytopenia and skin and mucosal bleeding. In patients with an indication for treatment, corticosteroids, intravenous immunoglobulin (IVIg) and anti-D are recommended as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994498e36640af7a0e231f4a3b3b3a02
https://doi.org/10.1016/j.transci.2021.103246
https://doi.org/10.1016/j.transci.2021.103246
Publikováno v:
Medicine Science, Vol 7, Iss 1, Pp 235-237 (2018)
Vildagliptin is a new generation theurapeutic agent of diabetes mellitus which belongs to dipeptidyl peptidase-IV inhibitor class acting via the incretin hormone system. It has moderate glycemic efficacy, a low propensity of causing hypoglycaemia and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3800395352e75d65b34cd94cb40c88ca
http://www.ejmanager.com/fulltextpdf.php?mno=265066
http://www.ejmanager.com/fulltextpdf.php?mno=265066
Publikováno v:
Turkiye Klinikleri Journal of Internal Medicine. 3:81-83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a11185a8464dfa66025ef5a4a0f83bb
https://doi.org/10.5336/intermed.2018-60577
https://doi.org/10.5336/intermed.2018-60577